Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.

Literature DB >> 33027576

STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.

Natalia S Chaimowitz¹, Sophia J Ebenezer¹, I Celine Hanson¹, Mark Anderson², Lisa R Forbes³.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2020 PMID： 33027576 DOI： 10.1056/NEJMc2022226

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. How anti-ageing drugs could boost COVID vaccines in older people.

Authors: Cassandra Willyard
Journal: Nature Date: 2020-10 Impact factor: 49.962

2. Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

Authors: Emilie W Borgström; Marie Edvinsson; Lucía P Pérez; Anna C Norlin; Sara L Enoksson; Susanne Hansen; Anders Fasth; Vanda Friman; Olle Kämpe; Robert Månsson; Hernando Y Estupiñán; Qing Wang; Tan Ziyang; Tadepally Lakshmikanth; Carl Inge E Smith; Petter Brodin; Peter Bergman
Journal: J Clin Immunol Date: 2022-09-02 Impact factor: 8.542

3. JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia.

Authors: Jacob M Rosenberg; Joshua M Peters; Travis Hughes; Caleb A Lareau; Leif S Ludwig; Lucas R Massoth; Christina Austin-Tse; Heidi L Rehm; Bryan Bryson; Yi-Bin Chen; Aviv Regev; Alex K Shalek; Sarah M Fortune; David B Sykes
Journal: Med (N Y) Date: 2022-01-14

4. Chronic mucocutaneous candidiasis, pancytopenia, and systemic mycosis in a patient with STAT1 gene mutation ineffectively treated with ruxolitinib.

Authors: Stanisława Bazan-Socha; Ada Gradzikiewicz; Magdalena Celińska-Lowenhoff; Aleksandra Matyja-Bednarczyk; Anna Maciołek; Katarzyna Bąbol-Pokora
Journal: Cent Eur J Immunol Date: 2022-05-10 Impact factor: 1.634

STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.

1. How anti-ageing drugs could boost COVID vaccines in older people.

2. Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

3. JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia.

4. Chronic mucocutaneous candidiasis, pancytopenia, and systemic mycosis in a patient with STAT1 gene mutation ineffectively treated with ruxolitinib.

Review 5. The TWEAK/Fn14/CD163 axis-implications for metabolic disease.

Review 6. Type 1 diabetes mellitus: much progress, many opportunities.

Review 7. Endocrinopathies in Inborn Errors of Immunity.

Review 8. Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes.

9. Identification of Sorafenib as a Treatment for Type 1 Diabetes.

Review 10. Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.